Edit the message. Rewrite the future.

OUR SCIENCE

A one letter difference.
A whole new story.

RNA editing holds great promise to rewrite what’s possible for patients. Since the discovery of the first generation of editing technologies, researchers have been working to overcome the inherent complexity of these initial approaches to develop viable new treatments for patients.

Our foundational platform for RNA editing – Oligonucleotide Promoted Editing of RNA (OPERA) – is inspired by the elegance and simplicity of the natural processes that many species, including humans, use to make transient, reversible changes to genetic instructions

About us

We work different.

Korro Bio was founded from our drive to find new pathways to what’s possible. Our team is committed to turning extraordinary scientific insights into life-changing new treatments for people with debilitating and life-threatening diseases.

OUR APPROACH

Edit the message. Repair the protein.

Discover our innovative approach to treating Alpha-1 Antitrypsin Deficiency (AATD) using mRNA editing and how we aim to transform the lives of those affected by this condition.

Join us

Write the next chapter of your career. 

Do you like to look at things differently? We take historically complex methodologies and strip them down to their most basic science to deliver sophisticated therapies for those with debilitating disease. If you share our vision, we invite you to join us on this journey.